Preface | p. xv |
Additional resources | p. xvii |
Problems at the end of chapters | p. xviii |
Review journals | p. xix |
About the author | p. xxi |
Why eat? | p. 1 |
Objectives | p. 1 |
The need for energy | p. 1 |
Units of energy | p. 3 |
Metabolic fuels | p. 3 |
The need for carbohydrate and fat | p. 3 |
The need for protein | p. 4 |
The need for micronutrients-minerals and vitamins | p. 4 |
Hunger and appetite | p. 5 |
Hunger and satiety-short-term control of feeding | p. 5 |
Long-term control of food intake and energy expenditure | p. 6 |
Appetite | p. 8 |
Taste and flavor | p. 8 |
Why do people eat what they do? | p. 9 |
The availability and cost of food | p. 9 |
Religion, habit, and tradition | p. 10 |
Luxury status of scarce and expensive foods | p. 11 |
The social functions of food | p. 11 |
Key points | p. 12 |
Enzymes and metabolic pathways | p. 13 |
Objectives | p. 13 |
Chemical reactions: breaking and making covalent bonds | p. 13 |
Equilibrium | p. 15 |
Catalysts | p. 15 |
Enzymes | p. 16 |
Specificity of enzymes | p. 18 |
The stages in an enzyme-catalyzed reaction | p. 19 |
Units of enzyme activity | p. 20 |
Factors affecting enzyme activity | p. 20 |
Effect of pH | p. 20 |
Effect of temperature | p. 21 |
Effect of substrate concentration | p. 22 |
Experimental determination of K[subscript m] and V[subscript max] | p. 23 |
Enzymes with two substrates | p. 25 |
Cooperative (allosteric) enzymes | p. 26 |
Inhibition of enzyme activity | p. 26 |
Irreversible inhibitors | p. 27 |
Competitive reversible inhibitors | p. 28 |
Noncompetitive reversible inhibitors | p. 29 |
Uncompetitive reversible inhibitors | p. 29 |
Coenzymes and prosthetic groups | p. 30 |
Coenzymes and metal ions in oxidation and reduction reactions | p. 30 |
Metal ions | p. 31 |
Riboflavin and flavoproteins | p. 31 |
The nicotinamide nucleotide coenzymes: NAD and NADP | p. 32 |
The classification and naming of enzymes | p. 34 |
Metabolic pathways | p. 35 |
Linear and branched pathways | p. 37 |
Spiral or looped reaction sequences | p. 37 |
Cyclic pathways | p. 38 |
Enzymes in clinical chemistry and medicine | p. 40 |
Measurement of metabolites in blood, urine and tissue samples | p. 40 |
Measurement of enzymes in blood samples | p. 40 |
Assessment of vitamin nutritional status | p. 41 |
Key points | p. 42 |
The role of ATP in metabolism | p. 47 |
Objectives | p. 47 |
The adenine nucleotides | p. 47 |
Functions of ATP | p. 48 |
The role of ATP in endothermic reactions | p. 49 |
Transport of materials across cell membranes | p. 51 |
Protein binding for concentrative uptake | p. 51 |
Metabolic trapping | p. 52 |
Active transport | p. 52 |
P-type transporters | p. 52 |
ABC-transporters | p. 52 |
The sodium pump | p. 54 |
The role of ATP in muscle contraction | p. 55 |
Creatine phosphate in muscle | p. 56 |
Phosphorylation of ADP to ATP | p. 58 |
Oxidative phosphorylation: the phosphorylation of ADP to ATP linked to the oxidation of metabolic fuels | p. 60 |
The mitochondrion | p. 61 |
The mitochondrial electron transport chain | p. 63 |
Phosphorylation of ADP linked to electron transport | p. 67 |
Coupling of electron transport, oxidative phosphorylation, and fuel oxidation | p. 69 |
Uncouplers | p. 70 |
Respiratory poisons | p. 71 |
Key points | p. 73 |
Digestion and absorption | p. 75 |
Objectives | p. 77 |
The gastrointestinal tract | p. 75 |
Digestion and absorption of carbohydrates | p. 78 |
The classification of carbohydrates | p. 78 |
Monosaccharides | p. 79 |
Sugar alcohols | p. 81 |
Disaccharides | p. 81 |
Reducing and nonreducing sugars | p. 81 |
Polysaccharides: starches and glycogen | p. 83 |
Nonstarch polysaccharides (dietary fiber) | p. 84 |
Carbohydrate digestion and absorption | p. 85 |
Starch digestion | p. 85 |
Digestion of disaccharides | p. 86 |
The absorption of monosaccharides | p. 87 |
Digestion and absorption of fats | p. 87 |
The classification of dietary lipids | p. 87 |
Fatty acids | p. 89 |
Phospholipids | p. 91 |
Cholesterol and the steroids | p. 92 |
Digestion and absorption of triacylglycerols | p. 93 |
Bile salts | p. 93 |
Lipid absorption and chylomicron formation | p. 95 |
Digestion and absorption of proteins | p. 96 |
The amino acids | p. 97 |
Protein structure and denaturation of proteins | p. 99 |
Secondary structure of proteins | p. 99 |
Tertiary and quaternary structures of proteins | p. 100 |
Denaturation of proteins | p. 101 |
Protein digestion | p. 101 |
Activation of zymogens of proteolytic enzymes | p. 102 |
Absorption of the products of protein digestion | p. 103 |
The absorption of vitamins and minerals | p. 103 |
Absorption of lipid-soluble vitamins and cholesterol | p. 103 |
Absorption of water-soluble vitamins | p. 104 |
Absorption of vitamin B[subscript 12] | p. 104 |
Absorption of minerals | p. 105 |
Iron absorption | p. 106 |
Key points | p. 107 |
Energy nutrition-the metabolism of carbohydrates and fats | p. 115 |
Objectives | p. 115 |
Estimation of energy expenditure | p. 116 |
Indirect calorimetry and the respiratory quotient | p. 116 |
Long-term measurement of energy expenditure-the dual isotopically labeled water method | p. 117 |
Calculation of energy expenditure | p. 117 |
Basal metabolic rate | p. 118 |
Energy costs of physical activity | p. 118 |
Diet-induced thermogenesis | p. 120 |
Energy balance and changes in body weight | p. 122 |
Metabolic fuels in the fed and fasting states | p. 123 |
The fed state | p. 123 |
The fasting state | p. 125 |
Energy-yielding metabolism | p. 127 |
Glycolysis-the (anaerobic) metabolism of glucose | p. 127 |
Transfer of NADH from glycolysis into the mitochondria | p. 129 |
The reduction of pyruvate to lactate: anaerobic glycolysis | p. 131 |
The pentose phosphate pathway-an alternative to glycolysis | p. 133 |
The pentose phosphate pathway in red blood cells-favism | p. 134 |
The metabolism of pyruvate | p. 135 |
The oxidation of pyruvate to acetyl CoA | p. 135 |
Oxidation of acetyl CoA-the citric acid cycle | p. 136 |
The citric acid cycle as a pathway for metabolic inter conversion | p. 139 |
Complete oxidation of four-and five-carbon compounds | p. 140 |
The metabolism of fats | p. 140 |
Carnitine and the transport of fatty acids into the mitochondrion | p. 142 |
The [beta]-oxidation of fatty acids | p. 144 |
Ketone bodies | p. 145 |
Tissue reserves of metabolic fuels | p. 147 |
Synthesis of fatty acids and triacylglycerols | p. 147 |
Unsaturated fatty acids | p. 150 |
Synthesis of triacylglycerol | p. 151 |
Plasma lipoproteins | p. 151 |
Chylomicrons | p. 153 |
Very low density lipoproteins, intermediate density lipoprotein, and low density lipoproteins | p. 154 |
High density lipoproteins | p. 155 |
Glycogen | p. 155 |
Glycogen utilization | p. 156 |
Gluconeogenesis-the synthesis of glucose from noncarbohydrate precursors | p. 157 |
Key points | p. 158 |
Diet and health-nutrition and chronic diseases | p. 171 |
Objectives | p. 171 |
Chronic diseases (the "diseases of affluence") | p. 172 |
Types of evidence linking diet and chronic diseases | p. 172 |
Secular changes in diet and disease incidence | p. 173 |
International correlations between diet and disease incidence | p. 173 |
Studies of migrants | p. 174 |
Case-control studies | p. 175 |
Prospective studies | p. 176 |
Intervention studies | p. 177 |
Guidelines for a prudent diet | p. 178 |
Energy intake | p. 178 |
Fat intake | p. 179 |
Type of fat in the diet | p. 181 |
Carbohydrate intake | p. 184 |
Sugars in the diet | p. 184 |
Undigested carbohydrates (dietary fiber and nonstarch polysaccharides) | p. 185 |
Salt | p. 186 |
Alcohol | p. 186 |
Nutritional genomics: interactions between diet and genes | p. 188 |
Epigenetic modifications | p. 189 |
Free radicals, oxidative damage, and antioxidant nutrients | p. 189 |
Tissue damage by oxygen radicals | p. 190 |
Sources of oxygen radicals | p. 190 |
Reoxidation of reduced flavins | p. 190 |
The macrophage respiratory burst | p. 191 |
Formation of nitric oxide | p. 191 |
Nonenzymic formation of radicals | p. 191 |
Antioxidant nutrients and non-nutrients-protection against radical damage | p. 192 |
Superoxide dismutase, peroxidases, and catalase | p. 192 |
Glutathione peroxidase | p. 192 |
Vitamin E | p. 193 |
Carotenes | p. 193 |
Vitamin C | p. 194 |
Non-nutrient antioxidants | p. 194 |
Other protective compounds in foods | p. 194 |
Inhibition of cholesterol absorption or synthesis | p. 196 |
Inhibition of carcinogen activation and increased conjugation of activated metabolites | p. 196 |
Allyl sulfur compounds | p. 196 |
Glucosinolates | p. 197 |
Flavonoids | p. 199 |
Phytoestrogens | p. 199 |
Miscellaneous actions of phytochemicals | p. 200 |
Key points | p. 201 |
Overweight and obesity | p. 205 |
Objectives | p. 205 |
Desirable body weight | p. 205 |
Body mass index | p. 205 |
Measurement of body fat | p. 206 |
Determination of body density | p. 207 |
Determination of total body water or potassium | p. 208 |
Imaging techniques | p. 208 |
Measurement of whole-body electrical conductivity and impedance | p. 208 |
Measurement of skinfold thickness | p. 209 |
The problems of overweight and obesity | p. 209 |
Social problems of obesity | p. 209 |
The health risks of obesity | p. 211 |
The distribution of excess adipose tissue | p. 214 |
Obesity and the metabolic syndrome | p. 214 |
Insulin resistance and hyperinsulinism | p. 215 |
Adiponectin | p. 216 |
Macrophage infiltration of adipose tissue | p. 216 |
Excessive synthesis of cortisol | p. 216 |
The causes and treatment of obesity | p. 217 |
Energy expenditure | p. 217 |
Availability of food | p. 217 |
Control of appetite | p. 218 |
How obese people can be helped to lose weight | p. 219 |
Starvation | p. 219 |
Very low-energy diets | p. 220 |
Conventional diets | p. 220 |
Very low carbohydrate (ketogenic) diets | p. 221 |
Low glycemic index diets | p. 221 |
High fiber diets | p. 221 |
"Diets" that probably will not work | p. 222 |
Slimming patches | p. 223 |
Sugar substitutes | p. 223 |
Fat substitutes | p. 223 |
Pharmacological treatment of obesity | p. 223 |
Surgical treatment of obesity | p. 224 |
Help and support | p. 224 |
Key points | p. 225 |
Protein-energy malnutrition-problems of undernutrition | p. 229 |
Objectives | p. 229 |
Problems of deficiency | p. 229 |
Protein-energy malnutrition | p. 230 |
Marasmus | p. 232 |
Causes of marasmus and vulnerable groups of the population | p. 233 |
Disorders of appetite: anorexia nervosa and bulimia | p. 233 |
Malabsorption | p. 234 |
Food intolerance and allergy | p. 234 |
Cachexia | p. 235 |
Hypermetabolism in cachexia | p. 235 |
Increased protein catabolism in cachexia | p. 236 |
Kwashiorkor | p. 237 |
Factors in the etiology of kwashiorkor | p. 237 |
Rehabilitation of malnourished children | p. 238 |
Key points | p. 238 |
Protein nutrition and metabolism | p. 241 |
Objectives | p. 241 |
Nitrogen balance and protein requirements | p. 241 |
Dynamic equilibrium | p. 243 |
Mechanisms involved in tissue protein catabolism | p. 244 |
Protein requirements | p. 245 |
Protein requirements of children | p. 246 |
Protein losses in trauma and infection-requirements for convalescence | p. 247 |
Essential amino acids | p. 248 |
Protein quality and complementation | p. 249 |
Unavailable amino acids and protein digestibility | p. 250 |
Protein synthesis | p. 250 |
The structure and information content of DNA | p. 251 |
DNA replication | p. 253 |
The genetic code | p. 253 |
Ribonucleic acid | p. 254 |
Transcription to form messenger RNA | p. 256 |
Translation of mRNA-the process of protein synthesis | p. 257 |
Transfer RNA | p. 257 |
Protein synthesis on the ribosome | p. 258 |
The energy cost of protein synthesis | p. 260 |
Posttranslational modification of proteins | p. 261 |
The metabolism of amino acids | p. 261 |
Metabolism of the amino nitrogen | p. 262 |
Deamination | p. 262 |
Transamination | p. 263 |
The metabolism of ammonia | p. 264 |
The synthesis of urea | p. 266 |
Incorporation of nitrogen in biosynthesis | p. 268 |
The metabolism of amino acid carbon skeletons | p. 268 |
Key points | p. 270 |
The integration and control of metabolism | p. 283 |
Objectives | p. 283 |
Patterns of metabolic regulation | p. 283 |
Intracellular regulation of enzyme activity | p. 284 |
Allosteric modification of the activity of regulatory enzymes | p. 285 |
Control of glycolysis-the allosteric regulation of phosphofructokinase | p. 286 |
Feedback control of phosphofructokinase | p. 286 |
Feed-forward control of phosphofructokinase | p. 288 |
Substrate cycling | p. 289 |
Responses to fast-acting hormones by covalent modification of enzyme proteins | p. 289 |
Membrane receptors and G-proteins | p. 291 |
Cyclic AMP and cyclic GMP as second messengers | p. 291 |
Amplification of the hormone signal | p. 293 |
Inositol trisphosphate and diacylglycerol as second messengers | p. 294 |
Amplification of the hormone signal | p. 295 |
The insulin receptor | p. 296 |
Slow-acting hormones: changes in enzyme synthesis | p. 296 |
Amplification of the hormone signal | p. 298 |
Hormonal control in the fed and fasting states | p. 299 |
Hormonal control of adipose tissue metabolism | p. 300 |
Control of lipid metabolism in the liver | p. 301 |
Selection of fuel for muscle activity | p. 302 |
The effect of work intensity on muscle fuel selection | p. 302 |
Muscle fuel utilization in the fed and fasting states | p. 304 |
Regulation of fatty acid metabolism in muscle | p. 304 |
Diabetes mellitus-a failure of regulation of blood glucose concentration | p. 306 |
Adverse effects of poor glycemic control | p. 307 |
Key points | p. 308 |
Micronutrients-the vitamins and minerals | p. 317 |
Objectives | p. 317 |
The determination of requirements and reference intakes | p. 317 |
Dietary reference values | p. 318 |
Supplements and safe levels of intake | p. 324 |
The vitamins | p. 324 |
Vitamin A | p. 327 |
Vitamin A vitamers and international units | p. 327 |
Metabolism of vitamin A and provitamin A carotenoids | p. 328 |
Carotene dioxygenase and the formation of retinol from carotenes | p. 328 |
Plasma retinol-binding protein (RBP) | p. 329 |
Metabolic functions of vitamin A | p. 330 |
Vitamin A in vision | p. 330 |
Retinoic acid and the regulation of gene expression | p. 330 |
Vitamin A deficiency-night blindness and xerophthalmia | p. 332 |
Vitamin A requirements and reference intakes | p. 333 |
Assessment of vitamin A status | p. 333 |
Toxicity of vitamin A | p. 333 |
Vitamin D | p. 334 |
Vitamers and international units | p. 335 |
Absorption and metabolism of vitamin D | p. 335 |
Synthesis of vitamin D in the skin | p. 335 |
Metabolism to the active metabolite, calcitriol | p. 336 |
Metabolic functions of vitamin D | p. 337 |
The role of calcitriol in bone metabolism | p. 338 |
Vitamin D deficiency: rickets and osteomalacia | p. 338 |
Vitamin D requirements and reference intakes | p. 339 |
Vitamin D toxicity | p. 339 |
Vitamin E | p. 339 |
Vitamers and units of activity | p. 340 |
Absorption and metabolism of vitamin E | p. 340 |
Metabolic functions of vitamin E | p. 341 |
Hypocholesterolemic actions of tocotrienols | p. 342 |
Vitamin E deficiency | p. 342 |
Vitamin E requirements | p. 343 |
Indices of vitamin E status | p. 343 |
Vitamin K | p. 343 |
Vitamers of vitamin K | p. 344 |
Metabolic functions of vitamin K | p. 345 |
Vitamin K dependent proteins in bone | p. 346 |
Vitamin K deficiency and requirements | p. 346 |
Vitamin B[subscript 1] (thiamin) | p. 346 |
Absorption and metabolism of thiamin | p. 347 |
Metabolic functions of thiamin | p. 347 |
Thiamin deficiency | p. 348 |
Dry beriberi | p. 348 |
Wet beriberi | p. 349 |
Acute pernicious (fulminating) beriberi-shoshin beriberi | p. 349 |
The Wernicke-Korsakoff syndrome | p. 349 |
Thiamin requirements | p. 349 |
Vitamin B[subscript 2] (riboflavin) | p. 350 |
Absorption and metabolism of riboflavin | p. 350 |
Metabolic functions of the flavin coenzymes | p. 351 |
Riboflavin deficiency | p. 351 |
Resistance to malaria in riboflavin deficiency | p. 351 |
Riboflavin requirements | p. 352 |
Niacin | p. 352 |
Metabolism of niacin | p. 352 |
Unavailable niacin in cereals | p. 353 |
Absorption and metabolism of niacin | p. 354 |
Metabolism of the nicotinamide nucleotide coenzymes | p. 354 |
The synthesis of nicotinamide nucleotides from tryptophan | p. 354 |
Metabolic functions of niacin | p. 356 |
The role of NAD in ADP-ribosylation | p. 357 |
Pellagra-a disease of tryptophan and niacin deficiency | p. 357 |
Niacin requirements | p. 357 |
Niacin toxicity | p. 358 |
Vitamin B[subscript 6] | p. 358 |
Absorption and metabolism of vitamin B[subscript 6] | p. 359 |
Metabolic functions of vitamin B[subscript 6] | p. 359 |
Vitamin B[subscript 6] deficiency | p. 359 |
Vitamin B[subscript 6] requirements | p. 360 |
Assessment of vitamin B[subscript 6] status | p. 360 |
The tryptophan load test | p. 360 |
The methionine load test | p. 361 |
Non-nutritional uses of vitamin B[subscript 6] | p. 361 |
Vitamin B[subscript 6] toxicity | p. 361 |
Vitamin B[subscript 12] | p. 361 |
Metabolic functions of vitamin B[subscript 12] | p. 363 |
Vitamin B[subscript 12] deficiency: pernicious anemia | p. 363 |
Vitamin B[subscript 12] requirements | p. 364 |
Assessment of vitamin B[subscript 12] status | p. 364 |
The Schilling test for vitamin B[subscript 12] absorption | p. 364 |
Folic acid | p. 364 |
Folate vitamers and dietary equivalence | p. 365 |
Absorption and metabolism of folate | p. 366 |
Metabolic functions of folate | p. 366 |
Thymidylate synthetase and dihydrofolate reductase | p. 368 |
Methionine synthetase and the methyl-folate trap | p. 368 |
Methylenetetrahydrofolate reductase and hyperhomocysteinemia | p. 370 |
Folate deficiency: megaloblastic anemia | p. 370 |
Folate requirements | p. 371 |
Folate in pregnancy | p. 371 |
Higher levels of folate intake | p. 371 |
Assessment of folate status | p. 372 |
Histidine metabolism-the FIGLU test | p. 372 |
The dUMP suppression test | p. 372 |
Biotin | p. 373 |
Absorption and metabolism of biotin | p. 373 |
Metabolic functions of biotin | p. 373 |
Biotin deficiency and requirements | p. 374 |
Pantothenic acid | p. 375 |
Absorption, metabolism, and metabolic functions of pantothenic acid | p. 375 |
Coenzyme A and acyl carrier protein | p. 375 |
Pantothenic acid deficiency; safe and adequate levels of intake | p. 375 |
Vitamin C (ascorbic acid) | p. 376 |
Absorption and metabolism of vitamin C | p. 377 |
Metabolic functions of vitamin C | p. 377 |
Copper-containing hydroxylases | p. 377 |
[alpha]-Ketoglutarate-linked iron-containing hydroxylases | p. 378 |
Vitamin C deficiency: scurvy | p. 378 |
Anemia in scurvy | p. 379 |
Vitamin C requirements | p. 379 |
Possible benefits of high intakes of vitamin C | p. 380 |
Pharmacological uses of vitamin C | p. 380 |
Toxicity of vitamin C | p. 381 |
Assessment of vitamin C status | p. 381 |
Minerals | p. 382 |
Calcium | p. 382 |
Osteoporosis | p. 382 |
Minerals that function as prosthetic groups in enzymes | p. 383 |
Cobalt | p. 383 |
Copper | p. 383 |
Iron | p. 383 |
Molybdenum | p. 384 |
Selenium | p. 384 |
Zinc | p. 385 |
Minerals that have a regulatory role in neurotransmission, as enzyme activators or in hormones | p. 385 |
Calcium | p. 385 |
Chromium | p. 385 |
Iodine | p. 385 |
Magnesium | p. 387 |
Manganese | p. 387 |
Sodium and potassium | p. 387 |
Minerals known to be essential, but whose function is unknown | p. 387 |
Silicon | p. 387 |
Vanadium | p. 387 |
Nickel and tin | p. 387 |
Minerals that have effects in the body, but whose essentiality is not established | p. 388 |
Fluoride | p. 388 |
Lithium | p. 388 |
Other minerals | p. 388 |
Key points | p. 388 |
Appendix | p. 391 |
Glossary | p. 393 |
Index | p. 403 |
Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.